Liu F, Pinz K, Ma Y, et al. First-in-human CLL1-DC33 compound CAR T cells as a two-pronged approach for the treatment of refractory acute myeloid leukemia. EHA 2018; abstract S149.
Fase I-onderzoek naar IL-10-producerende anti-CD19 CAR T-cellen bij r/r B-cel ALL
dec 2025 | Leukemie